{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380865816802258564.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Takao Fujii"}],"foaf:familyName":[{"@value":"Fujii"}],"foaf:givenName":[{"@value":"Takao"}]}],"career":[{"institution":{"notation":[{"@value":"Department of Rheumatology and Clinical Immunology, Wakayama Medical University , Wakayama, Japan"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360865816802258688","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1093/mr/road098"},{"@type":"URI","@value":"https://academic.oup.com/mr/advance-article-pdf/doi/10.1093/mr/road098/52044920/road098.pdf"},{"@type":"URI","@value":"https://academic.oup.com/mr/article-pdf/34/1/1/54800091/road098.pdf"},{"@type":"PMID","@value":"37819199"}],"notation":[{"@value":"Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/mr/road098_ntbM9PPc0WDWqmqSx7W1Fi3g6C"},{"@type":"OPENAIRE","@value":"doi_dedup___::88ea76577db0b453b9bc2e407451bbe1_ntbM9PPc0WDWqmqSx7W1Fi3g6C"}]}